Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02834364
Brief Title: BRAF/MEK Inhibition in Relapsed/Refractory Multiple Myeloma (BIRMA) (GMMG-BIRMA)

First Submitted : June 13, 2016
First Submitted that Met QC Criteria : July 12, 2016
First Posted : July 15, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : May 3, 2021
Last Update Posted : May 4, 2021